FDA APPROVES GENENTECH’S AVASTIN (BEVACIZUMAB) PLUS CHEMOTHERAPY AS A TREATMENT FOR WOMEN WITH ADVANCED OVARIAN CANCER FOLLOWING INITIAL SURGERY – Avastin is now approved for ten distinct uses across ...

Primary endpoint of Overall Response Rate at Week 18 met, demonstrating clinical equivalence in patients with advanced non-squamous non-small cell lung cancer SAMSON-II is a randomized, double blind, ...

Bevacizumab biosimilar LY01008 demonstrated comparative safety, efficacy, immunogenicity, and pharmacokinetic profiles to the reference product Avastin when combined with paclitaxel and carboplatin in ...

Two interesting trials in ovarian cancer were presented yesterday with impressive results and a surprising prediction about their futures.Avastin (bevacizumab) and olaparib, a PARP inhibitor, were ...

Dublin, April 01, 2026 (GLOBE NEWSWIRE)-- The "Avastin (Bevacizumab) Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's ...

Adding Imfinzi and Avastin to transarterial chemoembolization led to a 23% reduction in the risk of progression or death in patients with liver cancer. Patients with unresectable hepatocellular ...

INCHEON, South Korea--(BUSINESS WIRE)--Celltrion Healthcare announced today that the European Commission (EC) has approved Vegzelma™ (CT-P16), a biosimilar bevacizumab referencing EU-approved Avastin ...

If you have cancer, your doctor may prescribe Avastin for you. It’s a prescription drug that’s used treat the following types of cancer in adults, in certain situations: Avastin comes as a liquid ...

Please provide your email address to receive an email when new articles are posted on . According to Singh, increased availability of anti-VEGF biosimilars will improve patient access and decrease ...

Nicholas G. Anderson, MD, leads a discussion on how the first ophthalmic formulation of bevacizumab may impact the wet AMD treatment paradigm. Jim Kenney, RPh, MBA: We don’t always get extrapolation ...